Evidence map›Paper›PMID 39668190›Full record

ArticleBone marrow transplantation2025

Immune checkpoint inhibitors therapy for solid organ malignancies after allogeneic hematopoietic stem cell transplantation: a retrospective study from the EBMT Transplant Complications Working Party.

J Brijs, C Peczynski, W Boreland, A Cuoghi, J Maertens, M Mohty, N Kröger, P Nakov, A E C Broers, M Eder and 10 more

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Bone marrow transplantation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

J BrijsDepartment of Hematology, University Hospitals Leuven, Leuven, Belgium. jan.brijs2@telenet.be.ORCID http://orcid.org/0000-0001-8476-0872
C PeczynskiEBMT Paris Study Office / CEREST-TC, INSERM UMR-S 938, Department of Hematology, Sorbonne University, Hôpital Saint Antoine, Paris, France.
W BorelandEBMT Paris Study Office / CEREST-TC, INSERM UMR-S 938, Department of Hematology, Sorbonne University, Hôpital Saint Antoine, Paris, France.
A CuoghiAzienda Ospedaliero-Universitaria di Modena, Modena, Italy.
J MaertensDepartment of Hematology, University Hospitals Leuven, Leuven, Belgium.ORCID http://orcid.org/0000-0003-4257-5980
M MohtyDepartment of Hematology, Sorbonne University, Hôpital Saint Antoine, Paris, France.ORCID http://orcid.org/0000-0002-7264-808X
N KrögerDepartment for Stem Cell Transplantation, University Medical Centre Hamburg, Hamburg, Germany.ORCID http://orcid.org/0000-0001-5103-9966
P NakovDivision for Stem Cell Transplantation and Cellular Immunotherapy, Department of Medicine II, University Hospital Schleswig-Holstein Campus Kiel, Kiel, Germany.ORCID http://orcid.org/0009-0002-5994-9731
A E C BroersDepartment of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands.
M EderDepartment of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
C Herrera ArroyoHospital Universitario Reina Sofia, Cordoba, Spain.
M KaufmannRobert Bosch Hospital, Stuttgart, Germany.
R RamBone Marrow Transplantation Unit, Hematology department, Tel Aviv Sourasky Medical Centre, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
N P M SchaapRadboud University Medical Centre, Nijmegen, Netherlands.
C GrahamEBMT Transplant Complications Working Party (TCWP), Paris, France.ORCID http://orcid.org/0000-0001-7874-7305
A MussettiEBMT Transplant Complications Working Party (TCWP), Paris, France.
O PenackEBMT Transplant Complications Working Party (TCWP), Paris, France.ORCID http://orcid.org/0000-0003-4876-802X
I MoiseevEBMT Transplant Complications Working Party (TCWP), Paris, France.
Z Peric *EBMT Transplant Complications Working Party (TCWP), Paris, France.ORCID http://orcid.org/0000-0001-9458-8025
H Schoemans *Department of Hematology, University Hospitals Leuven, Leuven, Belgium.ORCID http://orcid.org/0000-0002-7568-8239

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39668190

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.